KAILERA
Live / Allowed — Second extension granted (statement of use) (as of 27 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98676367
- Mark type
- Word mark
- Filed
- 31 Jul 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Gabriel M. Gillmeyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of metabolic and endocrine diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the fields of metabolic science and endocrine science
Owner
- KAILERA THERAPEUTICS, INC., Waltham, MA, US
- KAILERA THERAPEUTICS, INC., WALTHAM, MA, US
- Hercules CM NewCo, Inc., Dover, DE, US
Prosecution history
- 28 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jul 2026 — SOU EXTENSION 2 GRANTED
- 27 Jul 2026 — SOU EXTENSION 2 FILED
- 27 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2026 — SOU EXTENSION 1 GRANTED
- 06 Feb 2026 — SOU EXTENSION 1 FILED
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED